🇺🇸 FDA
Pipeline program

filgrastim

199/15107

Phase 1 small_molecule active

Quick answer

filgrastim for Fanconi's Anemia is a Phase 1 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Fanconi's Anemia
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials